Copyright Reports & Markets. All rights reserved.

Global Insulin Like Growth Factor I Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Insulin Like Growth Factor I Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Insulin Like Growth Factor I Market Size Growth Rate by Product
      • 1.4.2 CIGB-845
      • 1.4.3 Dusigitumab
      • 1.4.4 GM-6
      • 1.4.5 M-610.27
      • 1.4.6 M-630
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Insulin Like Growth Factor I Market Size Growth Rate by End User
      • 1.5.2 Alzheimer's Disease
      • 1.5.3 Breast Cancer
      • 1.5.4 Huntington Disease
      • 1.5.5 Muscular Dystrophy
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Insulin Like Growth Factor I Market Size
      • 2.1.1 Global Insulin Like Growth Factor I Revenue 2014-2025
      • 2.1.2 Global Insulin Like Growth Factor I Sales 2014-2025
    • 2.2 Insulin Like Growth Factor I Growth Rate by Regions
      • 2.2.1 Global Insulin Like Growth Factor I Sales by Regions
      • 2.2.2 Global Insulin Like Growth Factor I Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Insulin Like Growth Factor I Sales by Manufacturers
      • 3.1.1 Insulin Like Growth Factor I Sales by Manufacturers
      • 3.1.2 Insulin Like Growth Factor I Sales Market Share by Manufacturers
      • 3.1.3 Global Insulin Like Growth Factor I Market Concentration Ratio (CR5 and HHI)
    • 3.2 Insulin Like Growth Factor I Revenue by Manufacturers
      • 3.2.1 Insulin Like Growth Factor I Revenue by Manufacturers (2014-2019)
      • 3.2.2 Insulin Like Growth Factor I Revenue Share by Manufacturers (2014-2019)
    • 3.3 Insulin Like Growth Factor I Price by Manufacturers
    • 3.4 Insulin Like Growth Factor I Manufacturing Base Distribution, Product Types
      • 3.4.1 Insulin Like Growth Factor I Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Insulin Like Growth Factor I Product Type
      • 3.4.3 Date of International Manufacturers Enter into Insulin Like Growth Factor I Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Insulin Like Growth Factor I Sales by Product
    • 4.2 Global Insulin Like Growth Factor I Revenue by Product
    • 4.3 Insulin Like Growth Factor I Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Insulin Like Growth Factor I Breakdown Data by End User

    6 North America

    • 6.1 North America Insulin Like Growth Factor I by Countries
      • 6.1.1 North America Insulin Like Growth Factor I Sales by Countries
      • 6.1.2 North America Insulin Like Growth Factor I Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Insulin Like Growth Factor I by Product
    • 6.3 North America Insulin Like Growth Factor I by End User

    7 Europe

    • 7.1 Europe Insulin Like Growth Factor I by Countries
      • 7.1.1 Europe Insulin Like Growth Factor I Sales by Countries
      • 7.1.2 Europe Insulin Like Growth Factor I Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Insulin Like Growth Factor I by Product
    • 7.3 Europe Insulin Like Growth Factor I by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Insulin Like Growth Factor I by Countries
      • 8.1.1 Asia Pacific Insulin Like Growth Factor I Sales by Countries
      • 8.1.2 Asia Pacific Insulin Like Growth Factor I Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Insulin Like Growth Factor I by Product
    • 8.3 Asia Pacific Insulin Like Growth Factor I by End User

    9 Central & South America

    • 9.1 Central & South America Insulin Like Growth Factor I by Countries
      • 9.1.1 Central & South America Insulin Like Growth Factor I Sales by Countries
      • 9.1.2 Central & South America Insulin Like Growth Factor I Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Insulin Like Growth Factor I by Product
    • 9.3 Central & South America Insulin Like Growth Factor I by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Insulin Like Growth Factor I by Countries
      • 10.1.1 Middle East and Africa Insulin Like Growth Factor I Sales by Countries
      • 10.1.2 Middle East and Africa Insulin Like Growth Factor I Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Insulin Like Growth Factor I by Product
    • 10.3 Middle East and Africa Insulin Like Growth Factor I by End User

    11 Company Profiles

    • 11.1 Boehringer Ingelheim GmbH
      • 11.1.1 Boehringer Ingelheim GmbH Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Products Offered
      • 11.1.5 Boehringer Ingelheim GmbH Recent Development
    • 11.2 Genervon Biopharmaceuticals LLC
      • 11.2.1 Genervon Biopharmaceuticals LLC Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Products Offered
      • 11.2.5 Genervon Biopharmaceuticals LLC Recent Development
    • 11.3 MedImmune LLC
      • 11.3.1 MedImmune LLC Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 MedImmune LLC Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 MedImmune LLC Insulin Like Growth Factor I Products Offered
      • 11.3.5 MedImmune LLC Recent Development
    • 11.4 Regulaxis SAS
      • 11.4.1 Regulaxis SAS Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Regulaxis SAS Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Regulaxis SAS Insulin Like Growth Factor I Products Offered
      • 11.4.5 Regulaxis SAS Recent Development

    12 Future Forecast

    • 12.1 Insulin Like Growth Factor I Market Forecast by Regions
      • 12.1.1 Global Insulin Like Growth Factor I Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Insulin Like Growth Factor I Revenue Forecast by Regions 2019-2025
    • 12.2 Insulin Like Growth Factor I Market Forecast by Product
      • 12.2.1 Global Insulin Like Growth Factor I Sales Forecast by Product 2019-2025
      • 12.2.2 Global Insulin Like Growth Factor I Revenue Forecast by Product 2019-2025
    • 12.3 Insulin Like Growth Factor I Market Forecast by End User
    • 12.4 North America Insulin Like Growth Factor I Forecast
    • 12.5 Europe Insulin Like Growth Factor I Forecast
    • 12.6 Asia Pacific Insulin Like Growth Factor I Forecast
    • 12.7 Central & South America Insulin Like Growth Factor I Forecast
    • 12.8 Middle East and Africa Insulin Like Growth Factor I Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Insulin Like Growth Factor I Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Insulin Like Growth Factor I market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insulin Like Growth Factor I market based on company, product type, end user and key regions.

      This report studies the global market size of Insulin Like Growth Factor I in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin Like Growth Factor I in these regions.
      This research report categorizes the global Insulin Like Growth Factor I market by top players/brands, region, type and end user. This report also studies the global Insulin Like Growth Factor I market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Boehringer Ingelheim GmbH
      Genervon Biopharmaceuticals LLC
      MedImmune LLC
      Regulaxis SAS

      Market size by Product
      CIGB-845
      Dusigitumab
      GM-6
      M-610.27
      M-630
      Others
      Market size by End User
      Alzheimer's Disease
      Breast Cancer
      Huntington Disease
      Muscular Dystrophy
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Insulin Like Growth Factor I market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Insulin Like Growth Factor I market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Insulin Like Growth Factor I companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Insulin Like Growth Factor I submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Insulin Like Growth Factor I are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insulin Like Growth Factor I market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now